Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation
NCT ID: NCT01281410
Last Updated: 2011-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
106 participants
INTERVENTIONAL
2011-01-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training Immediately After Lung Transplantation
NCT05309551
Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant
NCT04783155
Inspiratory Muscle Training Post-Liver Transplant
NCT03130608
Inspiratory Muscle Training in Lung Transplant Candidates
NCT06370832
Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients
NCT07061444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard physiotherapy
Standard Physiotherapy without Inspiratory Muscle Training
No interventions assigned to this group
Inspiratory muscle training
Inspiratory muscle training with a device named Respifit in addition to the usual physiotherapy program
Inspiratory Muscle Training
Inspiratory Muscle Training with Respifit (5 times per week)
inspiratory muscle training
Inspiratory muscle training with a device named Respifit for patients receiving a hematopoetic stem cell transplantation (till 30 days after their transplantation)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inspiratory Muscle Training
Inspiratory Muscle Training with Respifit (5 times per week)
inspiratory muscle training
Inspiratory muscle training with a device named Respifit for patients receiving a hematopoetic stem cell transplantation (till 30 days after their transplantation)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 17 - 80 years old
* Informed consent
Exclusion Criteria
* Impaired vision
* Patient is not able to handle "Respifit"
17 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elisabethinen Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elisabethinen Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanns Hauser, MD
Role: STUDY_CHAIR
Elisabethinen Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elisabethinen Hospital
Linz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 462
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.